Characterization of the major physiologic phosphorylation site of human keratin 19 and its role in filament organization

被引:27
作者
Zhou, XJ
Liao, J
Hu, LR
Feng, L
Omary, MB
机构
[1] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94303 USA
[2] Stanford Univ, Ctr Digest Dis, Palo Alto, CA 94304 USA
[3] CLONTECH Labs, Palo Alto, CA 94303 USA
关键词
D O I
10.1074/jbc.274.18.12861
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Keratin polypeptide 19 (K19) is a type I intermediate filament protein that is expressed in stratified and simple-type epithelia, Little is known regarding K19 regulation or function, and the only other type I keratin that has been studied in terms of regulation is keratin 18 (K18), We characterized K19 phosphorylation as a handle to study its function. In vivo, serine is the major phosphorylated residue, and phosphopeptide mapping of (PO4)-P-32-labeled K19 generates one major phosphopeptide. Edman degradation suggested that the radiolabeled phosphopeptide represents K19 Ser-10 and/or Ser-35 phosphorylation, Mutation of Ser-10 or Ser-35 followed by transfection confirmed that Ser-35 is the major K19 phosphorylation site. Transfection of Ser-35 --> Ala K19 showed a filament assembly defect as compared with normal or with Ser-10 --> Ala K19, Comparison of K18 and K19 phosphorylation features in interphase cells showed that both are phosphorylated primarily at a single site, preferentially in the soluble versus the insoluble keratin fractions. K19 has higher basal phosphorylation, whereas K18 phosphorylation is far more sensitive to phosphatase type I and IIA inhibition. Our results demonstrate that Ser-35 is the major K19 interphase phosphorylation site and that it plays a role in keratin filament assembly. K19 and K18 phosphorylations share some features but also have distinct properties that suggest different regulation of type I keratins within the same cells.
引用
收藏
页码:12861 / 12866
页数:6
相关论文
共 46 条
[31]  
MCLEAN WHI, 1995, CURR OPIN CELL BIOL, V7, P118
[32]  
Michel M, 1996, J CELL SCI, V109, P1017
[33]   THE CATALOG OF HUMAN CYTOKERATINS - PATTERNS OF EXPRESSION IN NORMAL EPITHELIA, TUMORS AND CULTURED-CELLS [J].
MOLL, R ;
FRANKE, WW ;
SCHILLER, DL ;
GEIGER, B ;
KREPLER, R .
CELL, 1982, 31 (01) :11-24
[34]   IDENTIFICATION OF PROTEIN-IT OF THE INTESTINAL CYTOSKELETON AS A NOVEL TYPE-I CYTOKERATIN WITH UNUSUAL PROPERTIES AND EXPRESSION PATTERNS [J].
MOLL, R ;
SCHILLER, DL ;
FRANKE, WW .
JOURNAL OF CELL BIOLOGY, 1990, 111 (02) :567-580
[35]   IMMUNOHISTOCHEMICAL DEMONSTRATION OF KERATIN-19 EXPRESSION IN ISOLATED HUMAN HAIR-FOLLICLES [J].
NARISAWA, Y ;
HASHIMOTO, K ;
KOHDA, H .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1994, 103 (02) :191-195
[36]  
Omary M B, 1998, Subcell Biochem, V31, P105
[37]   Intermediate filament proteins of the liver: Emerging disease association and functions [J].
Omary, MB ;
Ku, NO .
HEPATOLOGY, 1997, 25 (05) :1043-1048
[38]  
OSHIMA RG, 1982, J BIOL CHEM, V257, P3414
[39]   COMPARISON OF MOUSE AND HUMAN KERATIN-18 - A COMPONENT OF INTERMEDIATE FILAMENTS EXPRESSED PRIOR TO IMPLANTATION [J].
OSHIMA, RG ;
MILLAN, JL ;
CECENA, G .
DIFFERENTIATION, 1986, 33 (01) :61-68
[40]   SEQUENCE OF CDNA CODING FOR HUMAN KERATIN-19 [J].
STASIAK, PC ;
LANE, EB .
NUCLEIC ACIDS RESEARCH, 1987, 15 (23) :10058-10058